Skip to main content
Equibles

PEREGRINE CAPITAL MANAGEMENT LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 764529 MINNEAPOLIS, MN
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Jul 17, 2026
Position Value
$7,641,740
+$425,972 QoQ
Shares Held
291,447
-4.8% QoQ
Ownership
0.232%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#58
of 271 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 37% Shared 0% None 63%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PEREGRINE CAPITAL MANAGEMENT LLC holds $180,703,045 across 20 Biotechnology names. ARQT ranks #14 (4.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 29,732 $27,584,457
2 TWST
Twist Bioscience Corp
 138,970 $14,297,233
3 MIRM
Mirum Pharmaceuticals, Inc.
 88,820 $10,398,157
4 XENE
Xenon Pharmaceuticals Inc.
 164,894 $9,953,001
5 BMRN
Biomarin Pharmaceutical Inc
 162,714 $9,310,495
6 AXSM
Axsome Therapeutics, Inc.
 37,285 $9,126,249
7 COGT
Cogent Biosciences, Inc.
 226,350 $8,759,745
8 PRAX
Praxis Precision Medicines, Inc.
 25,790 $8,634,234

All Filings in ARQT

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,641,740 291,447
2026-03-31 $7,215,768 306,272